Union Minister Shivraj Singh Chouhan will launch India’s first indigenous H5N1 bird flu vaccine, developed by ICAR-NIHSAD, in Bhopal on November 20, 2026.
H5N1 Bird Flu Vaccine: India is set to take a major step towards strengthening its poultry disease control system with the launch of its first indigenously developed vaccine against a specific strain of the H5N1 bird flu virus. Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan will dedicate the vaccine to the nation on November 20, 2026, at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal.
The H5N1 bird flu vaccine has been developed by scientists at ICAR-NIHSAD, Bhopal. It is an inactivated vaccine designed to protect poultry against the highly pathogenic avian influenza (HPAI) virus of clade 2.3.2.1a. This is the first vaccine of its kind developed indigenously in India against this particular H5N1 strain.
India Develops Indigenous Vaccine Against H5N1 Bird Flu
The development of the H5N1 bird flu vaccine is considered an important achievement for India’s animal healthcare and poultry sectors. The vaccine targets clade 2.3.2.1a, a strain that has been responsible for a significant number of bird flu outbreaks among chickens.
Until now, there has been no specific commercially available vaccine to protect poultry against this particular H5N1 clade. The indigenous vaccine is expected to address this gap and support efforts to control the spread of the virus in the country.
Its development also highlights the role of Indian scientific institutions in creating solutions for animal diseases that can affect farmers, businesses and public health.
also read:- IndiGo Flight Aborts Take-Off In Mangaluru Due To…
Bird Flu Outbreaks Cause Major Losses to Poultry Farmers
Highly Pathogenic Avian Influenza, commonly known as bird flu, is a serious viral disease that affects chickens and several other bird species. In severe outbreaks, mortality among infected birds can reach 100 per cent.
The disease creates significant financial challenges for poultry farmers. Large-scale culling of infected birds, restrictions on poultry trade and disruptions in the supply of poultry products can result in substantial economic losses.
India first detected bird flu in 2006. Since then, the country has recorded more than 500 combined outbreaks involving the H5N1 and H5N8 subtypes.
The economic impact can extend beyond individual poultry farms. A major bird flu outbreak could potentially reduce India’s GDP growth by 1.5 per cent. If the virus spreads without effective control, more than 20 per cent of the country’s poultry population could be at risk.
The 2006 outbreak alone reportedly caused direct and indirect losses estimated at ₹2,200 crore to ₹3,000 crore. An outbreak in Manipur also resulted in losses equivalent to 0.5 per cent of the state’s GDP.
H5N1 Virus Also Raises Public Health Concerns
H5N1 Bird Flu Vaccine is not only an agricultural concern but also a public health issue because certain strains of the virus can infect humans and other animals.
According to the World Health Organization (WHO), 1,003 human cases of H5N1 avian influenza have been reported across 25 countries, including India, since 2003. These infections have resulted in 479 deaths.
Research has also identified the H5N1 clade 2.3.2.1a strain as a major contributor to bird flu outbreaks in chickens. Infections involving this strain have been reported in different animal species, including mammals. Three human infection cases have also been reported in connection with this strain, according to the information provided.
These developments underline the importance of controlling the virus in poultry to reduce the risk of transmission to other animals and humans.
Shivraj Singh Chouhan to Dedicate Vaccine to the Nation in Bhopal
Union Minister Shivraj Singh Chouhan will formally dedicate the H5N1 bird flu vaccine to the nation on November 20, 2026. The event will take place at ICAR-NIHSAD in Bhopal, the institute responsible for developing the vaccine.
The vaccine is an inactivated formulation developed specifically against H5N1 HPAI virus clade 2.3.2.1a. It is intended to provide protection to poultry against the strain currently circulating in India.
The launch marks an important development in India’s efforts to strengthen its preparedness against highly pathogenic avian influenza. It could also help reduce the economic burden of future outbreaks on poultry farmers.
Why Is India’s Indigenous H5N1 Bird Flu Vaccine Important?
The launch of the H5N1 bird flu vaccine is significant because it addresses a specific gap in India’s poultry disease prevention system. With no specific commercial vaccine previously available against clade 2.3.2.1a, the indigenous development offers a targeted approach to tackling the virus.
Effective disease control can help protect poultry populations, support farmers’ livelihoods and reduce disruptions to the poultry industry. It is also an important part of limiting the potential spread of avian influenza across animal species.
The vaccine represents a major step in India’s efforts to develop domestic solutions for animal health challenges and strengthen its response to future bird flu outbreaks.
For More Hindi News: http://newz24india.com